Review of Current and Upcoming Second-Line Treatments for Primary Biliary Cholangitis

By sjmartinez • December 2, 2024

Cumpian NA, Choi G, Saab S. Review of Current and Upcoming Second-Line Treatments for Primary Biliary Cholangitis. Dig Dis Sci. 2024 Dec 2. doi: 10.1007/s10620-024-08742-w. Epub ahead of print. PMID: 39621183.

Tags: ALP, Bezafibrate, Digestive Diseases, Elafibranor, General Internal Medicine, Harbor UCLA, OCA, PBC, Publications, Resident, second-line, Seladelpar, UDCA

Liver Metabolomic Profiling Reveals Distinct Signatures Between Steatosis and Metabolic Dysfunction-Associated Steatohepatitis

Palomurto S, Flam E, Kaminska D, Virtanen KA, Kärjä V, Käkelä P, Pajukanta P, Eberlé D, Haas JT, Raverdy V, Caiazzo R, Pattou F, Staels[...]

Medications for Alcohol Use Disorder Among Patients With Severe Alcohol-Related Liver Disease

Sundaresh R, Singh J, Meza J, Saab S, Shetty A. Medications for Alcohol Use Disorder Among Patients With Severe Alcohol-Related Liver Disease. JAMA Netw Open.[...]

Quality of Gadoxetate-enhanced MRI versus US during Hepatocellular Carcinoma Screening in Participants with Cirrhosis

Lewis S, Wildman-Tobriner B, Cuevas J, Calle S, Bolger I, Wang K, Joshi H, Mankowski Gettle L, Yang JD, Min JH, Sirlin CB, Reeder SB,[...]